| Literature DB >> 30600599 |
Sylvia Schucht1, Rebecca Minso2, Christiane Lex1, Jochen Reiss3, Frauke Stanke2,4, Stephanie Tamm2, Andrea van Barneveld2, Burkhard Tümmler2,4.
Abstract
BACKGROUND: The impact of complex alleles on CFTR processing and function has yet not been investigated in native human tissue.Entities:
Keywords: CFTR bioassay; CFTR immunoblot; complex allele; cystic fibrosis; intestinal current measurement
Mesh:
Substances:
Year: 2019 PMID: 30600599 PMCID: PMC6393651 DOI: 10.1002/mgg3.526
Source DB: PubMed Journal: Mol Genet Genomic Med ISSN: 2324-9269 Impact factor: 2.183
Figure 1Intestinal current measurements of four rectal suction biopsies collected from (a) the elder (upper panel) and (b) the younger (lower panel) p.Phe508del/p.[Arg74;Val201Met;Asp1270Asn] compound heterozygous siblings. The original tracings show the responses (from left to right) to amiloride, forskolin/IBMX, genistein, carbachol, 4,4′‐Diisothiocyano‐2,2′‐stilbenedisulfonic acid (DIDS), and histamine. Please note that the measurements were performed in Mini‐Ussing chambers with tissue sliders with an aperture area of either 0.018 or 0.011 cm2. The registration of the blue tracing in (a) became invalid after exposure to DIDS because of technical reasons (gray bar)
Figure 2CFTR immunoblot. (a) Immunodetection of CFTR (from left to right) in lysates of rectal suction biopsies by immunoprecipitation (IP) and subsequent immunoblot from a healthy non‐CF subject (lane 2) and its IP bead control (lane 1), the elder p.Phe508del/p.[Arg74;Val201Met;Asp1270Asn] compound heterozygous index case (lane 3) and its IP bead control (lane 4) and in lysates of T84 cells (lane 5). The right panel shows electronically enhanced signals of lanes 2 and 3 of the blot in order to more clearly visualize the CFTR immunoreactive signals of the biopsies. (b) Immunodetection of CFTR by immunoblot of lysates of rectal suction biopsies of two healthy non‐CF subjects (lanes 1, 3; 87 µg each) and of the younger p.Phe508del/p.[Arg74;Val201Met;Asp1270Asn] compound heterozygous index case (lane 2; 87 µg) (lane 1–3) and of non‐CF 16HBE14o cells (lane 4, 15 µg; lane 5, 35 µg; lane 6, 50 µg). Vinculin signals are provided as a western blot loading control
Clinical and electrophysiological data of the two boys bearing p.Phe508del and the p.[Arg74;Val201Met;Asp1270Asn] complex allele at the date of intestinal current measurements (ICM) assessment compared to non‐cystic fibrosis (CF) subjects
| Subject 1 | Subject 2 | Non‐CF ( | |
|---|---|---|---|
| Current age (months) | 108 | 82 | |
| Age at the date of ICM (months) | 36 | 63 | |
| Age at diagnosis (months) | 25 | 29 | |
| Cause of diagnosis | respiratory | familiarity | |
| Pancreatic status | PS | PS | |
| FEV1 (% predicted) | 109 | 113 | |
| Lung clearance index | 8.0 | 7.8 | |
| Sweat chloride (mmol/L) | 42 | 45 | |
| ICM (µA/cm2): response to | |||
| IBMX/forskolin | 37 ± 18 | 33 ± 25 | 31 (20–54; 10–104) |
| Carbachol | 14 ± 2 | 81 ± 46 | 77 (43–144; 15–250) |
| Histamine | 13 ± 4 | 49 ± 31 | 72 (37–125; 14–250) |
Own in‐house data due to the lack of published multicenter reference data for Standard Operating Procedure 2.7.
Pancreatic status = exocrine pancreatic sufficient.